Insiders Updates Rhythm Pharmaceuticals Inc (RYTM) receives a Buy rating from Goldman Rhythm Pharmaceuticals Inc’s recently made public that its Chief Human Resources Officer Cramer Pamela J. unloaded Company’s shares for reported
Stock Earnings The Attractiveness of Investing In Rhythm Pharmaceuticals Inc (RYTM) is Growing Rhythm Pharmaceuticals Inc’s filing revealed that its Chief Financial Officer Smith Hunter C unloaded Company’s shares for reported $3.39 million